BioSpace News Archive

4D Path , creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Jennifer Levin Carter, MD, MPH, MBA, has joined the company’s distinguished advisory board. Dr. Carter has a longstanding passion for applying emerging technologies across precision medicine, digital heath and AI applications to improve patient access to healthcare. Dr. Carter is managing director of JLC Precision Heal

HTD1801 met primary endpoint in Phase 2 trial with statistically significant reduction in liver fat in patients with NASH and diabetes HTD1801 demonstrated broad beneficial effects in measures of glycemic control, liver injury and cardiovascular risk factors

- Unique angled implants available with the prodisc® L Total Disc Replacement System - Angled endplates expand the options available to surgeons to better address the varied lumbar anatomy and pathology of patients - 6 implant options now include angulation in the inferior endplates - prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine

Healio is pleased to announce PM360 has named Healio.com as one of the most innovative services of 2020. The all-new Healio was selected as part of PM360’s 9 th Annual Innovations Issue, recognizing the year’s most innovative services, compan

Genetesis, Inc. announced today that its flagship product, CardioFlux®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the diagnosis of myocardial ischemia and infarction in patients with symptoms suggestive of acute coronary syndrome. CardioFlux®, the most advanced commercially available magnetocardiograph (MCG), leverages highly sensitive room temperature magnetomet

Company Invites Individual and Institutional Investors, as well as Advisors and Analysts, to Attend Live, Interactive Presentations on Thursday, December 17, 2020

The partnership promotes an innovative, proven alternative to invasive assessment of coronary physiology

numares ’ Novel Multi-marker Kidney Function Testing Shows Promising Results in US Validation Study - Based on US clinical samples, leading NMR diagnostics company numares successfully finished validation of a multi-marker serum test of kidney function - GFR NMR uses a defined model for glomerular filtration rate (GFR) equation to assess kidney function, comprised of the analysis of several metabolites in serum together with age and sex.

Saving over 160 lives and reducing the incidence of cardiac arrest by nearly half; fundraising initiative launched to continue life-saving mission

The American College of Cardiology, in collaboration with Amgen and Veradigm, announced a new national study to transform care for acute coronary syndrome patients at risk for future cardiovascular events.